Concetta Saponaro Selected Research

sodium-hydrogen exchanger regulatory factor

1/2022	The Biological Relevance of NHERF1 Protein in Gynecological Tumors.
2/2020	Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients.
5/2018	NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.
11/2011	Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Concetta Saponaro Research Topics

Disease

16	Neoplasms (Cancer) 05/2022 - 11/2011
8	Breast Neoplasms (Breast Cancer) 05/2022 - 11/2011
4	Triple Negative Breast Neoplasms 05/2022 - 09/2019
3	Carcinogenesis 01/2022 - 09/2012
3	Inflammation (Inflammations) 04/2018 - 01/2010
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 09/2012
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 11/2021 - 04/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2017 - 01/2017
2	Hypoxia (Hypoxemia) 01/2013 - 11/2011
1	Adenoma (Adenomas) 01/2018
1	Blast Crisis (Blast Phase) 05/2017
1	Leukemia 01/2017
1	Hemangiosarcoma (Angiosarcoma) 02/2014
1	Familial Breast Cancer 01/2013
1	Cysts 04/2011
1	Neuroinflammatory Diseases 01/2011
1	Rheumatic Diseases (Rheumatism) 10/2007

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2011
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
4	sodium-hydrogen exchanger regulatory factorIBA 01/2022 - 11/2011
3	InflammasomesIBA 05/2022 - 01/2020
3	CytokinesIBA 01/2021 - 01/2011
3	CateninsIBA 07/2019 - 01/2014
2	Phenobarbital (Luminal)FDA Link 05/2022 - 09/2012
2	Biological ProductsIBA 01/2022 - 06/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 01/2013
2	Hormones (Hormone)IBA 01/2013 - 03/2012
2	LipopolysaccharidesIBA 03/2011 - 01/2010
1	nirogacestatIBA 01/2022
1	Pattern Recognition ReceptorsIBA 01/2020
1	NLR ProteinsIBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 09/2019
1	Imatinib Mesylate (Gleevec)FDA Link 05/2017
1	TubulinIBA 05/2017
1	Colchicine FDA LinkGeneric 05/2017
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	Glycogen Synthase KinasesIBA 01/2017
1	Sodium-Hydrogen ExchangersIBA 06/2015
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 02/2014
1	Bevacizumab (Avastin)FDA Link 02/2014
1	vandetanib (ZD6474)IBA 02/2014
1	Angiogenesis InhibitorsIBA 02/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2014
1	Monoclonal AntibodiesIBA 02/2014
1	Peptide Hydrolases (Proteases)FDA Link 08/2013
1	PAR-2 ReceptorIBA 08/2013
1	Tryptases (Tryptase)IBA 08/2013
1	Tumor Biomarkers (Tumor Markers)IBA 03/2012
1	human ERBB2 proteinIBA 11/2011
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2011
1	Estrogen ReceptorsIBA 11/2011
1	Complementary DNA (cDNA)IBA 04/2011
1	Polygalacturonase (Pectinase)IBA 04/2011
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2011
1	RibonucleoproteinsIBA 10/2007
1	AutoantibodiesIBA 10/2007

Therapy/Procedure

5	Therapeutics 01/2022 - 02/2014
1	Immunomodulation 11/2021
1	Immunotherapy 02/2020
1	Precision Medicine 04/2018